- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GBP510 (RBD 25μg/dose)- Stage 2
Total 31 results
-
SK Bioscience Co., Ltd.GlaxoSmithKline; Coalition for Epidemic Preparedness InnovationsActive, not recruitingCOVID-19 (Healthy Volunteers)Korea, Republic of
-
SK Bioscience Co., Ltd.Coalition for Epidemic Preparedness InnovationsCompletedCOVID-19 (Healthy Volunteers)Korea, Republic of
-
Korea University Guro HospitalKorean Center for Disease Control and PreventionActive, not recruitingCOVID-19 (Healthy Volunteers)Korea, Republic of
-
SK Bioscience Co., Ltd.GlaxoSmithKline; International Vaccine Institute; Coalition for Epidemic Preparedness...CompletedCovid19Thailand, Korea, Republic of, New Zealand, Philippines, Ukraine, Vietnam
-
Altheos, Inc.UnknownPrimary Open Angle Glaucoma | Ocular HypertensionUnited States
-
Helixmith Co., Ltd.UnknownIschemic Heart Disease | Acute Myocardial InfarctionKorea, Republic of
-
University of OxfordWellcome TrustRecruitingPlasmodium Vivax InfectionThailand
-
CohBar, Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI); The Methodist Hospital Research Institute; Center...Active, not recruitingHodgkin Disease | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
Brigham and Women's HospitalMclean HospitalTerminatedCancer | Anxiety DisorderUnited States
-
PhytoTech Therapeutics, Ltd.Completed
-
Boehringer IngelheimCompletedAtrial FibrillationUnited States, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, Norway, Phili... and more
-
RenJi HospitalCompleted
-
Indiana UniversityThe National Center for Complementary and Integrative HealthRecruitingKidney Disease, Chronic | CBD | Transplant ComplicationUnited States
-
Yale UniversityConnecticut Pharmaceutical SolutionsCompleted
-
Egyptian Liver HospitalWadi El Nil HospitalCompleted
-
GlaxoSmithKlineCompleted
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Far Eastern Memorial HospitalResearch Ethics Review CommitteeUnknownQuality of Life | Percentage of Annual Acute ExacerbationTaiwan
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingAcute Lymphoblastic Leukemia | Large B-cell LymphomaUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBlastic Plasmacytoid Dendritic Cell NeoplasmUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States